Protagonist Therapeutics Inc (PTGX):企業の財務・戦略的SWOT分析

◆英語タイトル:Protagonist Therapeutics Inc (PTGX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH190876FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Protagonist Therapeutics Inc (PTGX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Protagonist Therapeutics Inc (Protagonist) is a clinical-stage biopharmaceutical company that discovers and develops orally stable peptides as targeted therapies. The company through its proprietary technology platform develops structurally novel oral or injectable peptides for protein-protein interaction targets. Protagonist’s peptides specifically target biological pathways that are also targeted by currently marketed injectable antibody drugs. The company’s product candidates are intended for the treatment of inflammatory bowel disease and other gastrointestinal diseases and hematological disorders. It operates in the US and Australia. Protagonist is headquartered in Milpitas, California, the US.

Protagonist Therapeutics Inc Key Recent Developments

Nov 04,2020: Protagonist Therapeutics reports third quarter financial results and provides corporate update
Aug 13,2020: Protagonist appoints Sarah O’Dowd to Board of Directors
Aug 11,2020: Protagonist Therapeutics announces board change
Aug 06,2020: Protagonist Therapeutics reports second quarter financial results and provides corporate update
May 07,2020: Protagonist Therapeutics reports first quarter financial results and provides corporate update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Protagonist Therapeutics Inc – Key Facts
Protagonist Therapeutics Inc – Key Employees
Protagonist Therapeutics Inc – Key Employee Biographies
Protagonist Therapeutics Inc – Major Products and Services
Protagonist Therapeutics Inc – History
Protagonist Therapeutics Inc – Company Statement
Protagonist Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Protagonist Therapeutics Inc – Business Description
Protagonist Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Protagonist Therapeutics Inc – Strengths
Protagonist Therapeutics Inc – Weaknesses
Protagonist Therapeutics Inc – Opportunities
Protagonist Therapeutics Inc – Threats
Protagonist Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Protagonist Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Protagonist Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Protagonist Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 04, 2020: Protagonist Therapeutics reports third quarter financial results and provides corporate update
Aug 13, 2020: Protagonist appoints Sarah O’Dowd to Board of Directors
Aug 11, 2020: Protagonist Therapeutics announces board change
Aug 06, 2020: Protagonist Therapeutics reports second quarter financial results and provides corporate update
May 07, 2020: Protagonist Therapeutics reports first quarter financial results and provides corporate update
Mar 10, 2020: Protagonist Therapeutics reports fourth quarter and full year 2019 financial results
Nov 06, 2019: Protagonist Therapeutics reports third quarter 2019 financial results
Oct 31, 2019: Protagonist Therapeutics secures debt facility for up to $50 Million
Jun 07, 2019: Protagonist Therapeutics reports second quarter 2019 financial results
May 29, 2019: Protagonist Therapeutics appoints Don Kalkofen as chief financial officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Protagonist Therapeutics Inc, Key Facts
Protagonist Therapeutics Inc, Key Employees
Protagonist Therapeutics Inc, Key Employee Biographies
Protagonist Therapeutics Inc, Major Products and Services
Protagonist Therapeutics Inc, History
Protagonist Therapeutics Inc, Subsidiaries
Protagonist Therapeutics Inc, Key Competitors
Protagonist Therapeutics Inc, Ratios based on current share price
Protagonist Therapeutics Inc, Annual Ratios
Protagonist Therapeutics Inc, Annual Ratios (Cont...1)
Protagonist Therapeutics Inc, Interim Ratios
Protagonist Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Protagonist Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Protagonist Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Protagonist Therapeutics Inc (PTGX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Asda Stores Ltd:戦略・SWOT・企業財務分析
    Asda Stores Ltd - Strategy, SWOT and Corporate Finance Report Summary Asda Stores Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • APA Group:企業のM&A・事業提携・投資動向
    APA Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's APA Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Factor Therapeutics Ltd (FTT)-医療機器分野:企業M&A・提携分析
    Summary Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic candidate, VF-001 is a targeted growth factor w …
  • Van Lanschot Private Banking:企業の戦略・SWOT・財務情報
    Van Lanschot Private Banking - Strategy, SWOT and Corporate Finance Report Summary Van Lanschot Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Tecan Group Ltd (TECN):医療機器:M&Aディール及び事業提携情報
    Summary Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation sup …
  • Genuine Parts Company:戦略・SWOT・企業財務分析
    Genuine Parts Company - Strategy, SWOT and Corporate Finance Report Summary Genuine Parts Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sinohydro Corporation Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Sinohydro Corporation Co., Ltd (Sinohydro) a subsidiary ofPower Construction Corporation of Chinais a global engineering and construction company. It is a state-owned hydropower project contractor with focus on the development of residential, commercial, and industrial properties across the …
  • Arrowhead Pharmaceuticals Inc (ARWR):企業の財務・戦略的SWOT分析
    Summary Arrowhead Pharmaceuticals Inc (Arrowhead), formerly Arrowhead Research Corp, is a pharmaceutical company that develops and markets medicinal products. The company develops pipeline drugs that are being developed to treat chronic hepatitis B virus infection for the treatment of liver disease, …
  • Sosei Group Corp (4565):製薬・医療:M&Aディール及び事業提携情報
    Summary Sosei Group Corp (Sosei) is a biopharmaceutical company that develops and commercializes drugs. The company’s pipeline products include NorLevo, NVA237, QVA149 and SO-1105. Its NorLevo product is an oral emergency contraceptive; and SO-1105 is an antifungal agent, administered as a muco-adhe …
  • American Rheinmetall Munitions, Inc.:企業の戦略・SWOT・財務情報
    American Rheinmetall Munitions, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Rheinmetall Munitions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Harmony Gold Mining Co Ltd:企業の戦略・SWOT・財務情報
    Harmony Gold Mining Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Harmony Gold Mining Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Calamos Asset Management, Inc.
    Calamos Asset Management, Inc. - Strategy, SWOT and Corporate Finance Report Summary Calamos Asset Management, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Singapore Telecommunications Ltd (Z74):企業の財務・戦略的SWOT分析
    Singapore Telecommunications Ltd (Z74) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Arla Foods amba:企業のM&A・事業提携・投資動向
    Arla Foods amba - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Arla Foods amba Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Actividades de Construccion y Servicios SA:戦略・SWOT・企業財務分析
    Actividades de Construccion y Servicios SA - Strategy, SWOT and Corporate Finance Report Summary Actividades de Construccion y Servicios SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Moog Inc.:企業の戦略・SWOT・財務情報
    Moog Inc. - Strategy, SWOT and Corporate Finance Report Summary Moog Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • WEG SA:企業の戦略・SWOT・財務情報
    WEG SA - Strategy, SWOT and Corporate Finance Report Summary WEG SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Miromatrix Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Miromatrix Medical Inc (Miromatrix Medical) is a life science company that develops regenerative medicines. The company offers MIRODERM biologic wound matrix, MIROMESH biologic matrix, liver function restoration, kidney products, diabetes treatment and cortical strut. It creates biological r …
  • ON Semiconductor Corporation:企業の戦略・SWOT・財務情報
    ON Semiconductor Corporation - Strategy, SWOT and Corporate Finance Report Summary ON Semiconductor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • PVR Ltd:企業のM&A・事業提携・投資動向
    PVR Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PVR Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆